Davita (NYSE:DVA) had its price target upped by investment analysts at SunTrust Banks to $72.00 in a research note issued to investors on Wednesday, The Fly reports. The brokerage presently has a “hold” rating on the stock. SunTrust Banks’ price target points to a potential upside of 3.08% from the company’s previous close. SunTrust Banks also issued estimates for Davita’s Q4 2019 earnings at $1.67 EPS, FY2019 earnings at $5.34 EPS, Q1 2020 earnings at $1.27 EPS, Q2 2020 earnings at $1.42 EPS, Q3 2020 earnings at $1.41 EPS, Q4 2020 earnings at $1.48 EPS and FY2020 earnings at $5.58 EPS.

Other analysts have also recently issued reports about the stock. TheStreet upgraded shares of Davita from a “c+” rating to a “b-” rating in a research note on Wednesday, July 24th. Wolfe Research cut shares of Davita from an “outperform” rating to a “market perform” rating and set a $57.00 price objective for the company. in a research note on Friday, October 25th. UBS Group reduced their price objective on shares of Davita from $61.00 to $60.00 and set a “neutral” rating for the company in a research note on Thursday, August 22nd. Robert W. Baird cut shares of Davita from an “outperform” rating to a “neutral” rating and reduced their price objective for the stock from $70.00 to $65.00 in a research note on Friday, July 26th. Finally, ValuEngine upgraded shares of Davita from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Nine investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Davita presently has an average rating of “Hold” and a consensus price target of $64.81.

Shares of Davita stock opened at $69.85 on Wednesday. The firm has a fifty day simple moving average of $58.51 and a 200-day simple moving average of $55.70. The company has a current ratio of 1.12, a quick ratio of 1.10 and a debt-to-equity ratio of 1.90. Davita has a 1-year low of $43.40 and a 1-year high of $70.51. The stock has a market capitalization of $10.01 billion, a price-to-earnings ratio of 19.57, a PEG ratio of 0.62 and a beta of 1.59.

Davita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.53 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.29. Davita had a net margin of 3.68% and a return on equity of 18.03%. The business had revenue of $2.90 billion during the quarter, compared to analysts’ expectations of $2.85 billion. During the same period in the previous year, the company earned $0.56 earnings per share. Davita’s revenue for the quarter was up 2.0% on a year-over-year basis. As a group, research analysts predict that Davita will post 5.19 earnings per share for the current year.

A number of large investors have recently added to or reduced their stakes in DVA. Invesco Ltd. raised its stake in Davita by 56.2% during the 2nd quarter. Invesco Ltd. now owns 3,662,685 shares of the company’s stock valued at $206,063,000 after purchasing an additional 1,317,725 shares during the last quarter. Par Capital Management Inc. raised its stake in Davita by 40.6% during the 2nd quarter. Par Capital Management Inc. now owns 4,159,000 shares of the company’s stock valued at $233,985,000 after purchasing an additional 1,201,300 shares during the last quarter. Pictet Asset Management Ltd. raised its stake in Davita by 3,290.3% during the 2nd quarter. Pictet Asset Management Ltd. now owns 1,132,521 shares of the company’s stock valued at $63,716,000 after purchasing an additional 1,168,020 shares during the last quarter. DekaBank Deutsche Girozentrale raised its stake in Davita by 1,512.8% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 724,095 shares of the company’s stock valued at $40,159,000 after purchasing an additional 679,199 shares during the last quarter. Finally, Wedge Capital Management L L P NC raised its stake in Davita by 1,543.5% during the 3rd quarter. Wedge Capital Management L L P NC now owns 619,437 shares of the company’s stock valued at $35,351,000 after purchasing an additional 581,746 shares during the last quarter. Hedge funds and other institutional investors own 91.00% of the company’s stock.

About Davita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

See Also: What is a SEC Filing?

The Fly

Analyst Recommendations for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.